Back

Prognostic value of left ventricle global constructive work in patients with cardiac amyloidosis

26 August 2022 (14:15 - 15:00)
Organised by:
Congress Presentation Part of: Diagnostic methods in cardiac amyloidosis and other rare cardiomyopathies Imaging ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Jolien Geers

UZ Brussel, Jette (Belgium)

6 More presentations in this session

Presentation thumbnail
The predictive value of left atrial diameter for thrombotic risk in patients with left ventricular noncompaction
Doctor W. Xu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Cardiac injury before and after COVID-19. A longitudinal MRI study
Doctor T. Althoff (Berlin, DE)
Abstract Slides
Presentation thumbnail
Early subclinical systolic dysfunction detected by two-dimensional speckle tracking systolic strain in patients with hereditary TTR amyloidosis
Miss L. Squassante Capeline (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Validation of an electrocardiographic algorithm for the detection of cardiac amyloidosis
Doctor L. Schrutka (Vienna, AT)
Abstract Slides
Presentation thumbnail
Echocardiographic evolution of patients undergoing 99mTc-DPD scintigraphy for suspected cardiac amyloidosis
Mrs N. Ramos Lopez (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Diagnostic methods in cardiac amyloidosis and other rare cardiomyopathies

The Event

Event poster

ESC Congress 2022

26 August 2022 14:15 CET
You may be interested in
thumbnail
Congress Presentation
The added role of myocardial work in anderson-fabry or amyloidosis cardiomyopathy
22 May 2023
thumbnail
Congress Presentation
Prognostic value of cardiac biomarkers in patients with transthyretin deposition cardiac amyloidosis.
29 June 2021
thumbnail
Congress Presentation
Global Constructive Work is associated with ventricular arrythmias after cardiac resynchronization therapy
27 August 2023
thumbnail
Congress Presentation
Straining to predict mortality in low flow low gradient aortic stenosis patients undergoing TAVR: can GLS and myocardial work parameters improve outcomes?
11 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources